Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer
This study has been completed.
North Central Cancer Treatment Group
Information provided by:
National Cancer Institute (NCI)
First received: January 16, 2007
Last updated: June 17, 2012
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Primary Completion Date:||February 2009 (Final data collection date for primary outcome measure)|
Tan WW, Dueck AC, Flynn P, et al.: N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: A North Central Cancer Treatment Group Trial. [Abstract] 32nd Annual San Antonio Breast Cancer Symposium, December 9-13, 2009, San Antonio, Texas. A-4096, 2009.